In our study, using meta-regression, we found that serum cholesterol level was a significant confounder which could neutralize the protective effect of statins on BCR, which indicated that statins might reduce the risk of BCR by mediating hypercholesterolemia. The gene discussed is BCR; the disease is familial hypercholesterolemia.